Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions of enriched central nervous system stem cell and progenitor cell populations

Compositions of enriched central nervous system stem cell and progenitor cell populations

US Patent 7153686 · Granted Dec 26, 2006

Estimated economic value: $2,729,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD47 targeted therapies for the treatment of infectious disease2025
Non-genotoxic conditioning regimen for stem cell transplantation2025
Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells2025
Dosing parameters for CD47 targeting therapies to hematologic malignancies2025
Methods for achieving therapeutically effective doses of anti-CD47 agents2025
Methods for treating myeloma by achieving therapeutically effective doses of ant2025
Engraftment of stem cells with a combination of an agent that targets stem cells2025
Dosing parameters for CD47 targeting therapies to hematologic malignancies2025
High affinity SIRP-alpha reagents and methods of using2025
Methods for manipulating phagocytosis mediated by CD472024
Targeting aneurysm disease by modulating phagocytosis pathways2024
Treatment of cancer with dual targeting of CD47 and EGFR2024